Global Respiratory Drugs Market to 2022 - PowerPoint PPT Presentation

View by Category
About This Presentation
Title:

Global Respiratory Drugs Market to 2022

Description:

The respiratory disorders market is forecast to rise from a value of $28.1 billion in 2015 to $46.6 billion in 2022, at a CAGR of 7.5%. To See Full Report @ – PowerPoint PPT presentation

Number of Views:33

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Global Respiratory Drugs Market to 2022


1
Global Respiratory Drugs Market to 2022
2
Description
  • The respiratory therapy area consists of
    indications that affect the respiratory system in
    different ways, such as the scarring of lung
    tissue, and excessive production of mucus in the
    airways, thereby decreasing lung function.
  • The causes of respiratory disorders vary
    significantly across each indication, and include
    factors such as environment, occupation, genetic
    predisposition and aging.
  • The treatment landscape for respiratory disorders
    has traditionally been dominated by small
    molecule therapies that aim to treat the disease
    symptoms, rather than the cause.

  • Continue.

3
  • The COPD and asthma treatment landscapes employ
    similar symptomatic treatments, including
    bronchodilators and inhaled corticosteroids.
  •  The treatment of respiratory disorders has
    developed significantly and approval of the
    products given in the year 2012 and 2014
    respectively.
  • The first biologic drug - omalizumab - approved
    in 2014 for the. treatment of severe asthma

4
Scope
  • The respiratory disorders market is characterized
    by entrenched, commercially successful
    therapies. 
  • The pipeline contains a range of molecule types
    and molecular targets, with a growing presence of
    targeted therapies.
  • Respiratory disorders clinical trials have an
    overall attrition rate of 89.1.
  • The respiratory disorders market is forecast to
    rise from a value of 28.1 billion in 2015 to
    46.6 billion in 2022, at a CAGR of 7.5.
  • Big pharma holds a notable presence in the
    market.

5
Reasons to buy
  • This report will allow you to
  • Understand the current clinical and commercial
    landscape through study of disease pathogenesis,
    diagnosis, prognosis.
  • Analyze the respiratory disorders pipeline and
    stratify by stage of development, molecule type,
    and molecular target.
  • Forecasting from 2015 to 2022 will provide an
    understanding of how epidemiology trends, new
    drug entries, and patent expirations will
    influence market value.
  • Identify the leading companies in the market
    determines how dependent the key companies in the
    market are on revenue derived from respiratory
    disorder products.

6
Table Of Content
  • Introduction 
  • Key Marketed Products
  • Pipeline Landscape Assessment
  • Multi-scenario Market Forecast to 2022
  • Company Analysis and Positioning
  • Strategic Consolidations
  • Appendix
  • List Of Tables

7
About JSB Market Research
  • JSB Market Research is one of the most
    significant databases of online market researches
    and intelligence reports and services. We
    specialize in providing market research reports
    for various industries. The online portal for
    marketing research deals with access to global
    market data and assists in providing expert
    insights and exposure on global companies,
    industries, products and trends.

8
To Know more
  • http//www.jsbmarketresearch.com/healthcare-medica
    l/r-global-respiratory-drugs-market-to-2022-276954
  • Contact Details
  • JSB Market Research
  • Phone 91 - 998 729 524
  • Email - enquiry_at_jsbmarketresearch.com 
  • Blog http//www.jsbmarketresearch.com/blog/
  • Website http//www.jsbmarketresearch.com
About PowerShow.com